Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 31/54
Blanche
Lincoln
U.S. Senate · D-AR
Taken from pharma & insurers
$24,900
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 31/54
Pharma & Health$24,650
Insurers & HMOs$250
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 31 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$24,900
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Then, after office
Lobbied for Pfizer at about $20,000 a month to keep the Medicare drug-price ban she voted for.
Source: The Intercept, 2021
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
Don't recognize a logo? Here's the key.
Pharma & Health$24,650
Johnson & Johnson$21,400
Eli Lilly$1,750
PhRMA$1,000
Amgen$500
Insurers & HMOs$250
Aetna$250